title: Use of mannanoligosacharides as an adjuvant treatment for gastrointestinal diseases and their effects on E.coli inactivated in dogs.
abstract: OBJECTIVE
  To evaluate the effects of mannanoligosacharides on dogs showing gastroenteritis.
  
  
  METHODS
  Sixteen dogs, 2-6 month-old, distributed into two groups: T1--animals with gastroenteritis receiving treatment for the disease + mannanoligosacharides (2 g/animal).; and T2--animals with gastroenteritis receiving just treatment for the disease. The animals were randomly included in the sample and all of them were submitted to blood and feces collection for coproculture. In the treatment for gastroenteritis antibiotic, antihemetic, vermifuge, vitamins and sorotheraphy were used. The parameters evaluated were the numbers of leucocytes, neutrophils, lymphocytes and the presence of enteropathogenic bacteria in feces.
  
  
  RESULTS
  The mannanoligosacharides was effective in eliminating pathogenic E. coli in 85.71% of the animals, while in the no-treated group only 25% of the animals were negative to E. coli.
  
  
  CONCLUSIONS
  The mannanoligosacharides is effective in the control of pathogenic E. coli and it can be indicated as an adjuvant treatment for gastroenteritis in dogs.
authors.affiliation: Postgraduate Program on Health and Development in West Central Region, Federal University of Mato Grosso do Sul, Campo Grande, Brazil.
authors.forename: Eliana Maria Ferreira
authors.initials: EM
authors.lastname: Gouveia
authors.forename: Iandara Schettert
authors.initials: IS
authors.lastname: Silva
authors.forename: Valter Joost Van
authors.initials: VJ
authors.lastname: Onselem
authors.forename: Rui Alberto Caetano
authors.initials: RA
authors.lastname: Corrêa
authors.forename: Camila Junqueira e
authors.initials: CJ
authors.lastname: Silva
mesh_terms: D000277:Adjuvants, Pharmaceutic; D000818:Animals; D019587:Dietary Supplements; D004283:Dog Diseases / Q000188:drug therapy* / Q000382:microbiology; D004285:Dogs; D004926:Escherichia coli / Q000187:drug effects*; D004927:Escherichia coli Infections / Q000188:drug therapy / Q000382:microbiology / Q000662:veterinary*; D005243:Feces / Q000382:microbiology; D005759:Gastroenteritis / Q000188:drug therapy / Q000662:veterinary*; D007958:Leukocyte Count; D008214:Lymphocytes / Q000097:blood; D008351:Mannans / Q000008:administration & dosage*; D009504:Neutrophils / Q000737:chemistry; D009844:Oligosaccharides / Q000008:administration & dosage*
chemical_list: D000277:Adjuvants, Pharmaceutic; D008351:Mannans; D009844:Oligosaccharides